NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
It seems demand is growing amongst women in perimenopause, menopause and postmenopause looking for multifaceted weight loss ...
Drugs like Ozempic have a positive impact on weight loss, though only for a short period, with long-term health implications ...
Results presented here showed patients who had significant weight loss prior to total hip arthroplasty with use of a GLP-1 receptor agonist experienced a decreased risk for complications but an ...
GLP-1 receptor agonists are transforming the landscape of medical weight loss, yet many individuals experience nutrient deficiencies and side effects such as nausea and appetite suppression.
Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 ...
Novo Nordisk (NVO) plans to study how its GLP-1 drugs marketed as Wegovy and Ozempic for obesity and diabetes can help tackle ...
Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...